The research will focus on the use of GLP-1 receptor agonist medications and their possible cognitive benefits in aging ...

Rosie O'Donnell showcased her new look after losing weight with the help of the antidiabetic medication Mounjaro.

Rosie O'Donnell showcased her new look after losing weight with the help of the antidiabetic medication Mounjaro.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...

On Saturday, friends and family joined at the Islamic Center of Omaha for Janidi’s funeral services.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

Glucagon-like peptide 1 receptor agonist treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms.

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

In patients with T2D, GLP-1s don’t increase the risk for acute pancreatitis, mitigate the risk for complications in those who ...